Drug maker Biota Holdings Limited (ASX:BTA) has inked a deal with US company Nabi Biopharmaceuticals.
The proposed merger will see Biota listed on the NASDAQ.
Biota’s says the alliance will achieve better value recognition for its product portfolio.
The merger will see Biota shareholders own about 74 per cent of the merged company.
Biota generated a net loss of $11 million for the first half of the 2012 financial year.
